Lipoprotein(a) Concentration and Cardiovascular Disease in a Group of Patients With Familial Hypercholesterolemia—A Lipid Clinic Experience
Clinical Cardiology · 2025
DOI: 10.1002/clc.70125 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Cardiology, 2025. Verfasst von J Kurdziel und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Metabolic Diseases and Diabetology, University Hospital, Krakow, Poland. Hauptthemen laut MEDLINE: Lipoprotein(a), Hyperlipoproteinemia Type II, Cardiovascular Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This study was supported by funding source UJ CM N41/DBS/000982..
Abstract (Originalsprache)
Background
High Lp(a) concentrations are linked to an increased risk of cardiovascular disease (CVD). However, more evidence is needed to assess the association of Lp(a) with CVD in different vascular beds. Hypothesis The aim was to assess the prevalence of increased Lp(a) levels and the association between Lp(a) levels and CVD in hypercholesterolemic patients.
Methods
We examined 220 patients (110 women) with suspicion of FH. The mean (SD) age was 49.1 (15.02) years, LDL‐C 3.49 (1.75) mmol/L, and the median (IR) Lp(a) concentration 0.15 (0.53) g/L.
Results
CVD was present in 24.5%, coronary artery disease (CAD) in 21.4% of the examined individuals. Patients with CVD and patients with CAD had higher Lp(a) levels than patients without these diseases ( p = 0.0403 and p = 0.0063, respectively); however, after adjustment for age and sex, only the difference in Lp(a) concentrations between persons with and without CAD remained significant. In total, 42.3% of patients who underwent carotid ultrasound examination had carotid plaques. We did not observe differences in Lp(a) levels between patients with or without plaques or correlations between Lp(a) and carotid IMT. In total, 28.3% of patients had Lp(a) concentrations in the high (> 0.5 g/dL), and 9.9% in the moderate‐risk category (0.3–0.5 g/L). We observed an association between Lp(a) risk categories and the presence of CVD ( p = 0.003) and CAD ( p = 0.0004) but not with the presence of carotid plaques.
Conclusions
We found a high prevalence of increased Lp(a) levels in a group of hyperlipidemic persons and strong associations of Lp(a) risk categories with CAD but not with carotid atherosclerosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Metabolic Diseases and Diabetology, University Hospital, Krakow, Poland.
- Department of Radiology, Jagiellonian University Medical College, Krakow, Poland.
- Department of Metabolic Diseases and Diabetology, Jagiellonian University Medical College, Krakow, Poland.
- Department of Nephrology, Jagiellonian University Medical College, Krakow, Poland.
- Statistical Laboratory, Institute of Nursing and Midwifery, Jagiellonian University Medical College, Faculty of Health Sciences, Krakow, Poland.
- Department of Medical Education, Center for Innovative Medical Education, Jagiellonian University Medical College, Krakow, Poland.
Förderung
- This study was supported by funding source UJ CM N41/DBS/000982.
Zitieren
APA
Kurdziel, J., Fedak, A., Kawalec, E., Miarka, P., Micek, A., Małecki, M., & Walus-Miarka, M. (2025). Lipoprotein(a) Concentration and Cardiovascular Disease in a Group of Patients With Familial Hypercholesterolemia—A Lipid Clinic Experience. Clinical Cardiology. https://doi.org/10.1002/clc.70125
Vancouver
Kurdziel J, Fedak A, Kawalec E, Miarka P, Micek A, Małecki M, et al. Lipoprotein(a) Concentration and Cardiovascular Disease in a Group of Patients With Familial Hypercholesterolemia—A Lipid Clinic Experience. Clinical Cardiology. 2025. doi:10.1002/clc.70125
BibTeX
@article{Kurdziel2025,
author = {Kurdziel, J and Fedak, A and Kawalec, E and Miarka, P and Micek, A and Małecki, M and Walus-Miarka, M},
title = {Lipoprotein(a) Concentration and Cardiovascular Disease in a Group of Patients With Familial Hypercholesterolemia—A Lipid Clinic Experience},
journal = {Clinical Cardiology},
year = {2025},
doi = {10.1002/clc.70125}
}
EUVIMED